217 related articles for article (PubMed ID: 37792265)
1. Dextromethorphan-Bupropion for the Treatment of Depression: A Systematic Review of Efficacy and Safety in Clinical Trials.
Akbar D; Rhee TG; Ceban F; Ho R; Teopiz KM; Cao B; Subramaniapillai M; Kwan ATH; Rosenblat JD; McIntyre RS
CNS Drugs; 2023 Oct; 37(10):867-881. PubMed ID: 37792265
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of AXS-05 (Dextromethorphan-Bupropion) in Patients With Major Depressive Disorder: A Phase 3 Randomized Clinical Trial (GEMINI).
Iosifescu DV; Jones A; O'Gorman C; Streicher C; Feliz S; Fava M; Tabuteau H
J Clin Psychiatry; 2022 May; 83(4):. PubMed ID: 35649167
[No Abstract] [Full Text] [Related]
3. Effect of AXS-05 (Dextromethorphan-Bupropion) in Major Depressive Disorder: A Randomized Double-Blind Controlled Trial.
Tabuteau H; Jones A; Anderson A; Jacobson M; Iosifescu DV
Am J Psychiatry; 2022 Jul; 179(7):490-499. PubMed ID: 35582785
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of dextromethorphan for the treatment of depression: a systematic review of preclinical and clinical trials.
Majeed A; Xiong J; Teopiz KM; Ng J; Ho R; Rosenblat JD; Phan L; Cao B; McIntyre RS
Expert Opin Emerg Drugs; 2021 Mar; 26(1):63-74. PubMed ID: 33682569
[TBL] [Abstract][Full Text] [Related]
5. Dextromethorphan-bupropion (Auvelity) for the Treatment of Major Depressive Disorder.
McCarthy B; Bunn H; Santalucia M; Wilmouth C; Muzyk A; Smith CM
Clin Psychopharmacol Neurosci; 2023 Nov; 21(4):609-616. PubMed ID: 37859435
[TBL] [Abstract][Full Text] [Related]
6. Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized-controlled trials comparison with venlafaxine.
Maneeton N; Maneeton B; Eurviriyanukul K; Srisurapanont M
Drug Des Devel Ther; 2013; 7():1053-62. PubMed ID: 24101861
[TBL] [Abstract][Full Text] [Related]
7. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
Olié JP; Gourion D; Montagne A; Rostin M; Poirier MF
Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291
[TBL] [Abstract][Full Text] [Related]
8. Combinations of dextromethorphan for the treatment of mood disorders - a review of the evidence.
Parincu Z; Iosifescu DV
Expert Rev Neurother; 2023 Mar; 23(3):205-212. PubMed ID: 36943010
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of aripiprazole or bupropion augmentation and switching in patients with treatment-resistant depression or major depressive disorder: A systematic review and meta-analysis of randomized controlled trials.
Ji M; Feng J; Liu G
PLoS One; 2024; 19(4):e0299020. PubMed ID: 38669232
[TBL] [Abstract][Full Text] [Related]
10. Antidepressants for smoking cessation.
Howes S; Hartmann-Boyce J; Livingstone-Banks J; Hong B; Lindson N
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD000031. PubMed ID: 32319681
[TBL] [Abstract][Full Text] [Related]
11. Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials.
Maneeton N; Maneeton B; Srisurapanont M; Martin SD
BMC Psychiatry; 2012 Sep; 12():160. PubMed ID: 23017200
[TBL] [Abstract][Full Text] [Related]
12. Dextromethorphan/Bupropion: A Novel Treatment for Patients With Major Depressive Disorder.
Willett KC; Bond LR; Morrill AM; Lorena D; Petru I
Am J Ther; 2024 Jan-Feb 01; 31(1):e24-e29. PubMed ID: 38231578
[TBL] [Abstract][Full Text] [Related]
13. Vortioxetine for depression in adults.
Koesters M; Ostuzzi G; Guaiana G; Breilmann J; Barbui C
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011520. PubMed ID: 28677828
[TBL] [Abstract][Full Text] [Related]
14. Antidepressants for people with epilepsy and depression.
Maguire MJ; Marson AG; Nevitt SJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
[TBL] [Abstract][Full Text] [Related]
15. Omega-3 fatty acids for depression in adults.
Appleton KM; Sallis HM; Perry R; Ness AR; Churchill R
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004692. PubMed ID: 26537796
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 fatty acids for depression in adults.
Appleton KM; Voyias PD; Sallis HM; Dawson S; Ness AR; Churchill R; Perry R
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004692. PubMed ID: 34817851
[TBL] [Abstract][Full Text] [Related]
17. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
18. Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
Hewett K; Gee MD; Krishen A; Wunderlich HP; Le Clus A; Evoniuk G; Modell JG
J Psychopharmacol; 2010 Aug; 24(8):1209-16. PubMed ID: 19939870
[TBL] [Abstract][Full Text] [Related]
19. Dextromethorphan/quinidine pharmacotherapy in patients with treatment resistant depression: A proof of concept clinical trial.
Murrough JW; Wade E; Sayed S; Ahle G; Kiraly DD; Welch A; Collins KA; Soleimani L; Iosifescu DV; Charney DS
J Affect Disord; 2017 Aug; 218():277-283. PubMed ID: 28478356
[TBL] [Abstract][Full Text] [Related]
20. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
